HKSE - Delayed Quote HKD
Laekna, Inc. (2105.HK)
13.660
-0.900
(-6.18%)
At close: April 25 at 4:08:21 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-278,303
-278,303
-295,603
-306,283
-198,007
Investing Cash Flow
208,192
208,192
-323,161
-4,220
-8,712
Financing Cash Flow
258,076
258,076
735,974
312,580
412,414
End Cash Position
634,323
634,323
440,815
323,070
296,412
Capital Expenditure
-1,913
-1,913
-1,313
-5,085
-9,121
Issuance of Capital Stock
213,159
213,159
709,794
301,082
412,538
Issuance of Debt
99,010
99,010
54,400
19,650
2,000
Repayment of Debt
-49,400
-49,400
-24,960
-2,000
--
Repurchase of Capital Stock
--
--
--
-5,029
--
Free Cash Flow
-280,216
-280,216
-296,916
-311,368
-207,128
12/31/2021 - 6/29/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
473A.F Adaptimmune Therapeutics plc
0.2180
+15.34%
0690.HK UNI-BIO GROUP
0.075
0.00%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
293.800
-4.67%
9969.HK InnoCare Pharma Limited
10.140
-3.61%
1952.HK Everest Medicines Limited
47.400
+2.16%
SION Sionna Therapeutics, Inc.
12.14
-3.65%
1672.HK ASCLETIS-B
6.280
-6.69%
2269.HK WuXi Biologics (Cayman) Inc.
22.800
-0.22%
1801.HK INNOVENT BIO
54.350
-1.09%
9926.HK Akeso, Inc.
98.900
-1.10%